若生智能
Drug Database
TE

teriparatide (Xinfutai)

✓ Approved

Shenzhen Salubris Pharmaceuticals Co., Ltd. · PTH1R · 重组蛋白

什么是 teriparatide？

teriparatide 是一种重组蛋白，由Shenzhen Salubris Pharmaceuticals Co., Ltd.研发。该药已获批，用于治疗相关适应症，给药途径：Injectable (Others)、Subcutaneous Injection。

药物档案

商品名Xinfutai
公司Shenzhen Salubris Pharmaceuticals Co., Ltd.
药物类别重组蛋白
分子靶点PTH1R
给药途径Injectable (Others), Subcutaneous Injection
状态Approved
来源： ClinicalTrials.gov, Shenzhen Salubris Pharmaceuticals Co., Ltd.

作用机制

分子靶点

teriparatide 作用于 1 个分子靶点：

PTH1Rparathyroid hormone 1 receptor (PTHR, EKNS)
需要更深入的分析？Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

teriparatide 针对 1 个适应症，涉及 1 个治疗领域。

治疗领域疾病/病症分期
Musculoskeletal and connective tissue disordersOsteoporosis✓ Approved

相关研究文献

PubMedExpert review of vaccines2026-06-13

Recent advances for the pharmaceutical production of highly attenuated poxviruses as viral vector platforms.

Weber Linus G LG, Wolff Michael W MW

Highly attenuated poxviruses serve as potent viral vectors, oncolytic agents, and therapeutic vaccines. They can accommodate and stably maintain a large genomic payload of foreign inserts. Their limited replication in human cells provides an excellent safety profile, but it concomitantly necessitates higher doses of infectious particles for full therapeutic efficacy. We review recent advances in bioprocesses for the pharmaceutical production of poxvirus-based vectors, focusing mainly on the vaccinia virus and the Orf virus. These include upstream processing using highly permissive cell substrates, optimized feeding strategies, and a virus phenotype that facilitates downstream processing. The study explores ongoing challenges and identifies strategies to adapt the downstream process to intensified upstream processes in order to achieve an economic end-to-end production. For notably increased virus yields of up to 2 log after amplification, we propose to replace classic adsorption chromatography by a collective and continuous purification platform for separating the virus from process-related impurities. Filtration operations facilitate process scalability while reducing volumes, which is beneficial for a flow-through polishing to meet pharmaceutical quality attributes. Combined with artificial intelligence modeling, these advancements alleviate financial pressures on healthcare systems and accelerate the production of novel vaccine candidates for clinical use.

PMID 42287073
阅读全文 →
PubMedScientific reports2026-06-13

Physico-mechanical and chemical performance of Portland cement modified with eggshell powder for sustainable construction.

Sanusi Abdulganiyu A, Ndububa Emmanuel Eberechukwu EE, Adeleke Adekunle Akanni AA, Obianyo Ifeyinwa Ijeoma II et al.

Cement is one of the most used materials in the construction industry. Its production contributes about 8% to the global emissions. This study explores the use of eggshell powder (ESP) that contains over 80% calcium carbonate (CaCO3) as a partial substitute for ordinary Portland cement (OPC), such as Types B and D, to substitute limestone within the cement matrix. The physical (consistency and setting time), compressive strength, and chemical (Scanning Electron Microscope with Energy Dispersive Spectroscopy, (SEM-EDS), and X-ray Diffraction (XRD), X-ray fluorescence (XRF)) properties were evaluated against British, Indian, and established standards in the literature. The results showed that cement consistency (31-35%) and setting times were within acceptable limits according to BS EN 197-1 (initial ≥ 60 min) and IS 8112 (initial ≥ 30 min, final ≤ 600 min). The mechanical strength of the samples exceeded the required strength (42.5 N/mm2) recommended by the British Standards, except for samples B10N and D10N, which showed strength reductions of 8.4% and 12.3%, respectively. The SEM-EDS and XRD analyses confirmed a high CaCO3 content in the samples. The study suggests that incorporating ESP into OPC should not exceed 5% by weight, as higher proportions could negatively impact the cement's physical and strength properties. This approach will promote environmental sustainability by using agro-waste while ensuring the cement remains suitable for construction.

PMID 42286071
阅读全文 →
PubMedLuminescence : the journal of biological and chemical luminescence2026-06-13

A Sustainable Spectrofluorimetric Method for Lisinopril Determination Using Erythrosin B Fluorescence Quenching With Mechanistic Characterization, Quantum Mechanical Modeling, and Green Chemistry Evaluation.

Abdelzaher Ahmed M AM, Al Kamaly Omkulthom O, Abdel Rahman Mona A MA

A novel, sensitive, and environmentally sustainable spectrofluorimetric method was developed for lisinopril quantification based on Erythrosin B fluorescence quenching. The method exploits static quenching through ground-state ion-pair complex formation between dianionic Erythrosin B and dicationic lisinopril at pH 6.0. Comprehensive mechanistic investigation employing temperature-dependent Stern-Volmer analysis, thermodynamic studies, Job's method, and PM3 semi-empirical quantum mechanical calculations confirmed the static quenching mechanism driven by electrostatic interactions with binding energy of -6.90 kcal/mol (-28.87 kJ/mol). Under optimized conditions (pH 6.0, 15 μg/mL Erythrosin B, excitation/emission, 533/555 nm), the method exhibited excellent linearity over 0.01-3.0 μg/mL (r = 0.9998) with high sensitivity (LOD, 3.1 ng/mL; LOQ, 9.2 ng/mL). Validation according to ICH Q2(R2) guidelines demonstrated excellent accuracy (99.8 ± 1.119%), precision (RSD < 1.63%), robustness, and selectivity. The method was successfully applied to pharmaceutical tablets (100.02 ± 1.079% recovery) and spiked human plasma (96.19%-105.72% recovery). Comprehensive sustainability assessment using RGB12 (whiteness, 88.0/100) and EPPI (total score, 83.8) confirmed the method's superior environmental sustainability and ideal green profile. The developed method offers significant advantages including commercially available reagents, elimination of derivatization or nanomaterial synthesis, and simple instrumentation, representing an environmentally friendly alternative for routine lisinopril determination in pharmaceutical quality control and bioanalytical applications.

PMID 42286975
阅读全文 →
PubMedScientific reports2026-06-13

Optimization algorithm for improving the prediction accuracy of API solubility in green solvent.

Alasiri Ali A, Lahiq Ahmed A AA, Alshehri Abdullah A AA

Supercritical carbon dioxide (SC-CO₂) is widely used as an environmentally friendly solvent in pharmaceutical processing, where accurate prediction of drug solubility is essential for efficient formulation design, extraction processes, and process optimization. However, predicting solubility behavior in supercritical systems remains challenging due to the nonlinear interactions between thermodynamic conditions and molecular properties. In this study, a hybrid artificial intelligence framework is developed to predict the solubility of active pharmaceutical ingredients (APIs) in SC-CO₂ using a curated dataset of more than 350 experimentally reported measurements. The proposed framework integrates interpretable deep learning (TabNet) and histogram-based gradient boosting (HGB) with three metaheuristic optimization algorithms, namely the Attack-Leave Optimizer (ALO), Energy Valley Optimizer (EVO), and Botox Optimization Algorithm (BOA), to improve hyperparameter tuning and predictive performance. Model evaluation was conducted using multiple statistical indicators, five-fold cross-validation, prediction interval bootstrapping, and multi-objective Pareto front analysis to assess accuracy and robustness. Among the evaluated configurations, the EVO-tuned TabNet model demonstrated the best predictive performance, achieving a coefficient of determination of [Formula: see text]along with narrow prediction intervals, indicating strong generalization capability within the studied thermodynamic domain. Statistical analysis using the Kruskal-Wallis test confirmed significant differences between optimizer performances ([Formula: see text]). These findings demonstrate that the proposed hybrid pipeline enhances predictive accuracy and interpretability within the thermodynamic domain represented by the compiled dataset. The framework therefore provides a statistically supported computational tool for assisting solvent selection and formulation analysis in supercritical systems, while broader generalization would benefit from future expansion of experimental solubility datasets.

PMID 42286012
阅读全文 →
PubMedJournal of pharmaceutical and biomedical analysis2026-06-13

A novel electrochemical sensing with MIP for highly selective and sensitive determination of anticancer drug erlotinib.

Erdogan-Kablan Sevilay S, Cetinkaya Ahmet A, Unal M Altay MA, Bellur Atici Esen E et al.

The sensitive and selective determination of targeted anticancer drugs is crucial for pharmaceutical quality control and therapeutic monitoring. Erlotinib (ERL), a tyrosine kinase inhibitor approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic or locally advanced non-small cell lung cancer (NSCLC), requires reliable analytical methods due to its clinical importance and potential impurities. In this study, an ultrasensitive nanomaterial-supported molecularly imprinted polymer (MIP)-based electrochemical sensor was rationally designed for the selective detection of ERL. Zinc oxide nanoparticles (ZnONPs) were incorporated to enhance the effective surface area and increase the density of active recognition sites. The polymeric film was synthesized using 3-aminophenyl boronic acid (3-APBA) as the functional monomer, ethylene glycol dimethacrylate (EGDMA) as the cross-linker, 2-hydroxyethyl methacrylate (HEMA) as the base monomer, and 2-hydroxy-2-methylpropiophenone as the initiator. The fabricated 3-APBA/ERL/ZnONPs@MIP-modified glassy carbon electrode (GCE) was characterized by scanning electron microscopy (SEM), electrochemical impedance spectroscopy (EIS), and cyclic voltammetry (CV). The sensor exhibited a linear response in the range of 1.0 × 10-13-1.0 × 10-12 M (100-1000 fM) with a limit of detection (LOD) of 1.89 × 10-14 M (18.9 fM) and a limit of quantification (LOQ) of 6.30 × 10-14 M (63.0 fM) (r = 0.997). Selectivity and specificity studies demonstrated that ERL could be accurately quantified even in the presence of structurally related drugs and ERL-related impurities at 1000-fold excess, yielding recovery values between 98.40% and 103.76%. The sensor was successfully applied to ERL determination in tablet dosage forms, demonstrating its suitability for pharmaceutical quality control. Furthermore, density functional theory (DFT) and Monte Carlo simulations elucidated the molecular recognition mechanism, revealing a precise "lock-and-key" fit of ERL within the imprinted cavities and supporting a target-induced "site-blocking" sensing mechanism.

PMID 42284916
阅读全文 →
PubMedJournal of pharmaceutical sciences2026-06-13

Change management considerations for orally inhaled and nasal drug products and other drug device combination products in the European Union.

Calderini Marielle M, Grand-Demars Beatrice B, Nagao Lee L

In this paper, the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS), discusses the current regulatory landscape associated with change management of orally inhaled and nasal drug products (OINDP) and other drug device combination products in the European Union. The paper also describes current challenges related to alignment of regulatory expectations, particularly for integral drug device combination products, and proposes topics for further discussion with regulatory agencies and stakeholders to help advance alignment. To further illustrate current challenges and industry approaches to meeting change management requirements, we also present results of an IPAC-RS benchmarking survey and case studies, and outcome from interactions with notified bodies and regulatory agencies. This document is intended to be used as a guideline for industry alignment.

PMID 42285437
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多teriparatide